MetLife Investment Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Sell |
|
|||||
|
2025
Q1 | $310K | Buy |
|
|||||
|
2024
Q4 | $267K | Sell |
|
|||||
|
2024
Q3 | $315K | Hold |
|
|||||
|
2024
Q2 | $252K | Buy |
|
|||||
|
2024
Q1 | $160K | Buy |
|
|||||
|
2023
Q4 | $147K | Hold |
|
|||||
|
2023
Q3 | $120K | Hold |
|
|||||
|
2023
Q2 | $136K | Hold |
|
|||||
|
2023
Q1 | $179K | Buy |
|
|||||
|
2022
Q4 | $103K | Sell |
|
|||||
|
2022
Q3 | $112K | Buy |
|
|||||
|
2022
Q2 | $95.2K | Sell |
|
|||||
|
2022
Q1 | $118K | Buy |
|
|||||
|
2021
Q4 | $38.8K | Sell |
|
|||||
|
2021
Q3 | $129K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $176K | Buy |
|